Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy

Differential diagnosis of genetic causes of left ventricular hypertrophy (LVH) is crucial for disease-specific therapy. We aim to describe the prevalence of Cardiac Amyloidosis (CA) among patients ≥40 years with an initial diagnosis of HCM referred for second opinion to national cardiomyopathy centres.

Source: International Journal of Cardiology - July 16, 2019 Category: Cardiology Authors: Niccol ò Maurizi, Valeria Rella, Carlo Fumagalli, Sabrina Salerno, Silvia Castelletti, Federica Dagradi, Margherita Torchio, Azzurra Marceca, Martino Meda, Gianfranco Parati, Beatrice Boschi, Francesca Girolami, Iacopo Olivotto, Lia Crotti, Franco Cecchi Source Type: research